Clinical Impotance of the CA 19-9 Staining Pattern in Colorectal Cancer Tissue.

Nippon Daicho Komonbyo Gakkai Zasshi
doi 10.3862/jcoloproctology.45.7_992
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Society of Coloproctology

Related search

Highly Sensitive Plasmonic Detection of the Pancreatic Cancer Biomarker CA 19-9

Scientific Reports
Multidisciplinary
2017English

Monitoring Ovarian Carcinoma With CA 125, CA 19–9, CA 15–3 and CEA in Serum, Ascites and Tumor Tissue

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
1986English

CA 19-9 and CA 125 Determination by Immunoluminometric Assay

Clinical Chemistry and Laboratory Medicine
BiochemistryMedicineClinical Biochemistry
1990English

Elevated Serum CA 19-9 Levels in Dermoid Cyst: A Predictor of Ovarian Torsion and Tissue Necrosis?

International Journal of Reproduction, Contraception, Obstetrics and Gynecology
2019English

Increased Serum CA 19-9 Antibodies in Sjogren's Syndrome.

Postgraduate Medical Journal
Medicine
1998English

Distinct Pattern of Matrix Metalloproteinase 9 and Tissue Inhibitor of Metalloproteinase 1 mRNA Expression in Human Colorectal Cancer and Liver Metastases

British Journal of Cancer
Cancer ResearchOncology
1995English

Predictive Value of Carcinoembryonic and Carbohydrate Antigen 19-9 Related to Some Clinical, Endoscopic and Histological Colorectal Cancer Characteristics

Journal of Medical Biochemistry
BiochemistryClinical Biochemistry
2016English

Supra‐elevated CA 19‐9 in a Benign Hepatic Cystadenoma

HPB
HepatologyGastroenterology
2004English

CA 19‐9‐producing Gastric Carcinoma: A Case Report

Advances in Digestive Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy